Journal
EMERGING INFECTIOUS DISEASES
Volume 24, Issue 8, Pages 1561-1564Publisher
CENTERS DISEASE CONTROL
DOI: 10.3201/eid2408.180228
Keywords
-
Categories
Funding
- National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 AI046464, R01 AI114701]
- Research Facilities Improvement Program grant from National Center for Research Resources, National Institutes of Health [C06 RR016226]
Ask authors/readers for more resources
Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported cases are attributable to encapsulated meningococcal strains. We describe a case in which a nongroupable meningococcal strain, which rarely causes disease in healthy persons, caused fatal disease in an eculizumab recipient despite meningococcal vaccination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
